Publications

  1. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. World Neurosurg 2017 Jul; 103:655-663 Epub 2017 Apr 24
    View PubMed
  2. Derek R. Johnson, Campeau Norbert G. , MD. Dual-Energy CT Differentiates Contrast The Neurohospitalist.2017;().
  3. Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. AJNR Am J Neuroradiol 2017 Apr; 38 (4):678-684 Epub 2017 Jan 26
    View PubMed
  4. Maloney PR, Yamaki VN, Kumar R, Johnson D, Hunt C, Jentoft ME, Clarke M. Osteosclerosis Secondary to Metastatic Oligodendroglioma. Rare Tumors 2017 Mar 24; 9 (1):6837 Epub 2017 Mar 31
    View PubMed
  5. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. Revisiting adjuvant radiotherapy after gross total resection of World Health Organization grade II meningioma World Neurosurgery 2017; 103:655-63
  6. Korfel A, Schlegel U, Johnson DR, Kaufmann T, Giannini C, Hirose T. Case-Based Review: Primary CNS Lymphoma Neuro-Oncology Practice.2016;In Press().
  7. Fogh SE, Johnson DR, Barker FG 2nd, Brastianos PK, Clarke JL, Kaufmann TJ, Oberndorfer S, Preusser M, Raghunathan A, Santagata S, Theodosopoulos PV. Case-Based Review: meningioma. Neurooncol Pract 2016 Jun; 3 (2):120-134 Epub 2016 Jan 13
    View PubMed
  8. Johnson DR, Fogh SE, Giannini C, Kaufmann TJ, Raghunathan A, Theodosopoulos PV, Clarke JL. Case-Based Review: Newly Diagnosed Glioblastoma Neuro-Oncology Practice.;2(3)106-111.
  9. Porter AB, Lachance DH, Johnson DR. Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control 2015 Feb; 26 (2):179-85 Epub 2014 Nov 25
    View PubMed
  10. Johnson DR, Galanis E. Medical management of high-grade astrocytoma: current and emerging therapies. Semin Oncol. 2014 Aug; 41(4):511-22. Epub 2014 Jun 30.
    View PubMed
  11. Johnson DR, Leeper HE, Uhm JH. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis. Cancer. 2013 Oct 1; 119(19):3489-95. Epub 2013 Jul 18.
    View PubMed
  12. Johnson DR, Wefel JS. Relationship between cognitive function and prognosis in glioblastoma. CNS Oncol. 2013 Mar; 2(2):195-201.
    View PubMed
  13. Johnson DR, Galanis E. Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep 2013 Feb; 15 (1):56-63
    View PubMed
  14. Johnson DR, O'Neill BP, Decker PA, Kosel ML, Lanzino G, Hammack JE. Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009. World Neurosurg 2013 Jan; 79 (1):110-5 Epub 2012 Apr 03
    View PubMed
  15. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012 Nov 15; 118(22):5608-13. Epub 2012 May 08.
    View PubMed
  16. Kamel H, Johnson DR, Hegde M, Go AS, Sidney S, Sorel M, Hills NK, Johnston SC. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31. Epub 2011 May 05.
    View PubMed
  17. Johnson DR, Kaufmann TJ. Rapid symptomatic and radiographic evolution after presumed spontaneous infarction of a meningioma. Neurologist. 2012 Nov; 18(6):409-12.
    View PubMed
  18. Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol 2012 Jun; 14 (6):808-16 Epub 2012 Apr 16
    View PubMed
  19. Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol. 2012 May; 108(1):187-93. Epub 2012 Feb 25.
    View PubMed
  20. Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 2012 Apr; 107 (2):359-64 Epub 2011 Nov 02
    View PubMed
  21. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR. Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol 2011 Sep; 13 (9):1011-9 Epub 2011 July 12
    View PubMed
  22. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 2011 Sep 1; 174 (5):574-81 Epub 2011 July 08
    View PubMed
  23. Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro Oncol 2011 May; 13 (5):530-5
    View PubMed
  24. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011 Jan; 204 (1):13-8
    View PubMed
  25. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke. 2010 Jul; 41(7):1514-20. Epub 2010 May 27.
    View PubMed